Effect of acrylamide on biogenic amine levels, monoamine oxidase, and cathepsin D activity of rat brain.
D020106:Acrylamide; D000178:Acrylamides / Q000633:toxicity*; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D002402:Cathepsin D; D002403:Cathepsins / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D051381:Rats; D011919:Rats, Inbred Strains
D000178:Acrylamides; D001679:Biogenic Amines; D020106:Acrylamide; D008995:Monoamine Oxidase; D002403:Cathepsins; D002402:Cathepsin D; D004298:Dopamine; D009638:Norepinephrine